Company

Butterfly sciences was founded in 2009 to develop gene therapies for HIV and aging. Since founding, the company has completed patents in antibody based diagnostics for flow cytometry and developed gene therapy candidates and strategies for treatment of HIV-AIDS.

Butterfly Sciences additionally provides consulting services for biotech investment evaluations, and also for patients wishing to optimize treatment in oncology and other immunologically related areas.

Brian Hanley is the founder and chief scientist for Butterfly Sciences. Brian holds a Microbiology PhD from UC Davis with honors completed in under three years. Brian guest lectured for the MBA program at Santa Clara University for 6 years and has years of operations experience in the USA and Central Asia in startups and early stage companies. He has publications in epidemiology, biotechnology, economics and a portfolio of patents in addition to chapters on biodefense and terrorism in DHS/West Point sponsored books. Since founding Butterfly Sciences, Brian has developed gene therapies for HIV treatment   and new approaches to flow-cytometry diagnostics.

 

Advisory Board

Enoch-BaldwinEnoch Baldwin is associate professor of molecular and cellular biology, and chemistry at UC Davis. Enoch has been studying structure and functional groups of large protein molecules for most of his career, using cloning and molecular biology to produce modified molecules as part of structural analysis. Enoch’s interests are in macromolecular structure and function, macromolecular interactions, protein sequence-structure-function relationships, enzyme mechanisms, and X-ray structure determination. He brings a high level of expertise to problems in specialized cloning and engineering or protein molecules to maintain function while changing various characteristics.

 

Albert-van-Geelen-PortraitAlbert van Geelen has extensive research experience in virology, including work with recombinant CMV based hantavirus vaccine for his Ph.D., and unraveling mechanisms of Kaposi’s Sarcoma Herpes Virus (KSHV) for postdoctoral work. Following on that, Albert has been studying fetal lung tissue development and mechanisms of Respiratory Syncytial Virus (RSV) pathogenesis in perinatal lamb model in the Ackerman laboratory at Iowa State .  He brings excellent immunology and virology expertise and great practical experience with all aspects molecular biology.

 

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload CAPTCHA.